In search of fewer independent risk factors

被引:99
作者
Brotman, DJ [1 ]
Walker, E [1 ]
Lauer, MS [1 ]
O'Brien, RG [1 ]
机构
[1] Cleveland Clin Fdn, Dept Gen Internal Med, Cleveland, OH 44195 USA
关键词
D O I
10.1001/archinte.165.2.138
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
More than 1100 articles now appear annually investigating "independent risk factors" or "independent predictors" for various clinical outcomes. In medical research, independence is generally defined in a statistical sense: a variable is called an independent risk factor if it has a significant contribution to an outcome in a statistical model that includes. established risk factors. As such, independence is based on a specific statistical model and depends on the set of established risk factors included in that model. Even when strong statistical evidence indicates that a variable is an independent risk factor for an outcome, this does not necessarily indicate that the risk factor causally contributes to the outcome. The opposite is also true: risk factors that have causal relationships with the outcome will not necessarily prove to be independent risk factors. These are basic statistical principles that are too often given short shrift in medical research. Herein, we discuss the clinical implications conferred by the above definition of independence, primarily using examples from recent cardiovascular literature. A glossary and schema are provided to help clinicians and researchers understand and discuss these matters effectively.
引用
收藏
页码:138 / 145
页数:8
相关论文
共 50 条
  • [1] The Pravastatin Inflammation CRP Evaluation (PRINCE): Rationale and design
    Albert, MA
    Staggers, J
    Chew, P
    Ridker, PM
    [J]. AMERICAN HEART JOURNAL, 2001, 141 (06) : 893 - 898
  • [2] Uric acid and survival in chronic heart failure - Validation and application in metabolic, functional, and Hemodynamic staging
    Anker, SD
    Doehner, W
    Rauchhaus, M
    Sharma, R
    Francis, D
    Knosalla, C
    Davos, CH
    Cicoira, M
    Shamim, W
    Kemp, M
    Segal, R
    Osterziel, KJ
    Leyva, F
    Hetzer, R
    Ponikowski, P
    Coats, AJS
    [J]. CIRCULATION, 2003, 107 (15) : 1991 - 1997
  • [3] [Anonymous], 2011, Categorical data analysis
  • [4] Influence of HMG-CoA reductase inhibitors on markers of coagulation, systemic inflammation and soluble cell adhesion
    Bickel, C
    Rupprecht, HJ
    Blankenberg, S
    Espinola-Klein, C
    Rippin, G
    Hafner, G
    Lotz, J
    Prellwitz, W
    Meyer, J
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2002, 82 (01) : 25 - 31
  • [5] The association of heart-rate variability with cardiovascular risk factors and coronary artery calcification - A study in type 1 diabetic patients and the general population
    Colhoun, HM
    Francis, DP
    Rubens, MB
    Underwood, SR
    Fuller, JH
    [J]. DIABETES CARE, 2001, 24 (06) : 1108 - 1114
  • [6] Evidence that triglycerides are an independent coronary heart disease risk factor
    Cullen, P
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2000, 86 (09) : 943 - 949
  • [7] Association of body fat distribution and cardiovascular risk factors in children and adolescents
    Daniels, SR
    Morrison, JA
    Sprecher, DL
    Khoury, P
    Kimball, TR
    [J]. CIRCULATION, 1999, 99 (04) : 541 - 545
  • [8] Platelet activation in obese women -: Role of inflammation and oxidant stress
    Davì, G
    Guagnano, MT
    Ciabattoni, G
    Basili, S
    Falco, A
    Marinopiccoli, M
    Nutini, M
    Sensi, S
    Patrono, C
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (16): : 2008 - 2014
  • [9] Insulin resistance syndrome and left ventricular mass in healthy young people
    Davis, CL
    Kapuku, G
    Snieder, H
    Kumar, M
    Treiber, FA
    [J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2002, 324 (02) : 72 - 75
  • [10] Statins, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, are able to reduce superoxide anion production by NADPH oxidase in THP-1-derived monocytes
    Delbosc, S
    Morena, M
    Djouad, F
    Ledoucen, C
    Descomps, B
    Cristol, JP
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2002, 40 (04) : 611 - 617